BioAuxilium is a Canadian biotechnology company focused on the development and manufacturing of ready-to-use, custom assay kits based on the homogeneous (no-wash, add-and-read), sensitive and robust TR-FRET technology. Our products are commercialised through strategic alliances with industrial partners. Our mission is to provide new, rapid, easy-to-use products that simplify laboratory workflow and accelerate drug discovery & life science research.
Founded by accomplished scientists from PerkinElmer BioSignal, BioAuxilium provides a range of high-quality, customised assay kit development services across a number of areas including basic research, drug discovery, biologic quantification and biomarker detection.
BioAuxilium is based in Montréal (Québec, Canada) and has access to NEOMED Institute’s state-of-the-art laboratories and core facilities.